The 11th Annual UGA-FDA
Medical Device Regulations
Virtual Conference
University of Georgia Center for Continuing Education & Hotel, Athens, GA
- All - Day Virtual
Conference
- August 21, 2024
Conference)
Conference
Conference)
PROGRAM HIGHLIGHTS
Early registration through May 27, 2024, with up to $100 in savings!
On August 21, 2024, the 11th Annual Medical Device Regulations Conference (MDRC) brings together key stakeholders in the medical device industry and the FDA to share insights, and advancement that would support small business. The growth of the medical device industry is driven by small businesses that play a pivotal role in revolutionizing healthcare through groundbreaking technologies and solutions. Medical device regulations are constantly evolving and it is a challenge for small business within the medical device industry to keep themselves current. This year’s MDRC will be offered virtually as an opportunity to understand the complementary nature of information regarding current and forthcoming FDA policies, guidance, and regulations governing the medical device industry.
UGA-FDA MDRC will offer insights into many of the challenges faced by industry
and regulators regarding the following topics:
- To share knowledge exchange around the concepts of regulatory compliance to advance product quality and efficacy by assuring benefit to the patient.
- Enable participants to gain insights into emerging regulatory trends and requirements shaping the medical device industry.
- Educate attendees on navigating regulatory compliance requirements essential for medical devices in the market.
We look forward to seeing you August 21, 2024, at the 2024 UGA-FDA MDRC!
UGA Sponsored Workshop
(August 21*)
Workshop Topic: Global Development of Combination Products
The regulatory landscape surrounding the manufacturing and distribution of Combination Products poses significant complexities both in the United States and Europe. These combination products, can offer numerous advantages in terms of convenience, accuracy, and reduced risk of contamination. However, the regulatory frameworks governing these products in the two regions present challenges for manufacturers, regulators, and patients. The workshop will explore and highlight the key regulatory complexities associated using several examples of combination products both in the United States and Europe. With this learning the workshop attendees will work in groups to define regulatory strategy and requirements on an example combination product.